Boehringer Ingelheim
Express 5-HS
Express 5-HS
Couldn't load pickup availability
Express 5- HS is a modified-live virus for the vaccination of healthy, susceptible cattle. An aid in the reduction of respiratory diseases caused by Bovine Rhinotracheitis (IBR) virus, Bovine Virus Diarrhea (BVD) Types 1 and 2, Parainfluenza 3 (PI3) virus, and Bovine Respiratory Syncytial Virus (BRSV). Also, an aid in the prevention of disease caused by Haemophilus somnus. Express 5-HS may be used in pregnant females or calves nursing pregnant females, provided the females were vaccinated pre-breeding according to label directions with any Express FP vaccine.
Please see shipping information regarding vaccines before placing order. Free shipping on vaccine orders over$150.
Express 5-HS Features & Benefits
-
Time-tested, proven protection against respiratory disease
- Complies with Beef Quality Assurance guidelines for low-dosage and subcutaneous administration
Directions for Use:Â
Mix the accompanying bottle of diluent. Rehydrate the vaccine by aseptically adding the diluent to the vaccine vial. Mix well and use immediately. Using aseptic technique, inject 2 mL subcutaneously in front of the shoulder and midway of the neck, away from the suprascapular lymph node. If initial vaccination, repeat with any Express® vaccine containing BRSV MLV and H. somnus in 14 to 28 days. Calves vaccinated before 6 months of age should be revaccinated at 6 months. Revaccinate annually. Contact your veterinarian or the manufacturer for information on revaccination frequency.
Precautions:Â
Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products, except as specified on the label. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Injection site swelling may occur. Stressed cattle should not be vaccinated. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician. Inactivate unused contents before disposal.
Fetal health risks associated with vaccination of pregnant animals with this vaccine cannot be unequivocally determined by clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian.
No vaccine can be expected to have 100% efficacy under all conditions. A small number of calves persistently infected with BVD may have a devastating effect on herd health.
Note:Â
It is possible that healthy-appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. In view of these findings and suggested causes, BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy, immunocompetent, unstressed cattle
Manufacturer and/or Label Information
Manufacturer and/or Label Information
Dimensions
Dimensions
Care information
Care information
Let customers speak for us
